<< Back To HomePhase 2b Controlled Trial of M72/ASO1E Vaccine to Prevent Tuberculosis
Printable Copy |
|
Phase 2b Controlled Trial of M72/ASO1E Vaccine to Prevent Tuberculosis
O van der Meeren et al., NEJM, 25 October 2019
https://www.nejm.org/doi/full/10.1056/NEJMoa1803484